Medifast surprised the market with a strong earnings beat despite a 27.6% year-over-year sales drop—reporting $76.38M in revenue, better than Wall Street’s forecast. Their next-quarter revenue outlook and EPS beat expectations by significant margins, even as annual revenue continues its three-year decline. The company reaffirmed its full-year guidance, projecting $285M in revenue and $1 EPS—far exceeding analyst estimates—and saw its stock jump 12.8% post-earnings. Investors reacted positively to the upside, showing that beating forecasts can outweigh short-term revenue headwinds.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
